CLINICAL_TRIALS
research
· 2012-08-08
Clinical Trial Update: Thalidomide for Patients With Mild to Moderate Alzheimer's Disease [Phase 2, Phase 3]
Summary
An update on a Phase 2/3 clinical trial evaluating thalidomide for Alzheimer's disease.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Banner Health | Conditions: Alzheimer's Disease | Phase 2, Phase 3 | Status: UNKNOWN